Procurement Summary
Country: USA
Summary: Aienabled Discovery of Broadspectrum Smallmolecule Inhibitors for Filoviruses
Deadline: 17 Jul 2026
Posting Date: 20 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 141618423
Document Ref. No.: RRPV-AVAT_PATH-SM
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
AI-Enabled Discovery of Broad-Spectrum Small-Molecule Inhibitors for Filoviruses
Purpose: The purpose of this Request for Information (RFI) is to conduct market research to identify organizations with capabilities in artificial intelligence (AI) for application in the discovery and advancement of broad-spectrum, small-molecule therapeutics targeting filoviruses (e.g., Ebola virus (EBOV), Sudan virus (SUDV), Marburg virus (MARV)).
This RFI seeks information on technical capabilities, infrastructure, prior experience, and recommended approaches. Areas of interest include: AI-driven design, in vitro verification of hits, and early preclinical proof-of-concept evaluation. Information obtained through this RFI will inform acquisition planning and may shape the scope and structure of a future solicitation.
Respondents may propose teaming arrangements or partnerships to address the full scope of capabilities described in this RFI.
Request for Information
Respondents do not have to be a member of the RRPV consortium to submit a response for this RFI; however, they must be a member of the consortium to respond to any future request for project proposals (RPP) for this requirement. Please submit responses by email to [email protected] no later than
1pm EDT June 17th, 2026
Late responses will not be considered.
This RFI is for information gathering purposes only. It does not constitute a Request for Project Proposal (RPP) nor does it imply any obligation to issue a future solicitation, make any award, or pay any costs associated with responding to this RFI. Submission is voluntary and does not commit the responder to respond to any subsequent opportunities (if any) related to this topic. The RRPV will not return or provide feedback on any submissions, however, BARDA reserves the right to further engage with respondents in a Market Research Call to clarify understanding of submitted information. All responses to this RFI will be treated as sensitive informati...
Notice ID: rrpv-avat_path-sm
Department/Ind. Agency: health and human services, department of
Sub-tier: office of assistant secretary for preparedness and response
Office: aspr administration for strategic preparedness and response
Product Service Code: an13 - health r&d services; health care services; experimental development
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Inactive Dates: aug 01, 2026
Inactive Policy: 15 days after response date
Documents
Tender Notice
Documents.zip